Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vancomycin vs Placebo for NAAT+/Toxin- C. Difficile in Hematology Oncology
NCT03030248Phase 2Completed
- Sponsor
- Medical College of Wisconsin
- Start
- Jun 2018
- Primary completion
- Jun 2020
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vancomycin in Clostridioides difficile infection (CDI), sponsored by Medical College of Wisconsin. Started Jun 2018; status: completed.
02
Drugs
vancomycin
03
Conditions
Clostridioides difficile infection (CDI)
Beyond the preview
Go deeper on NCT03030248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03030248.